Project Resurgence Communication Trial

University of Pennsylvania11,120 enrolled

Overview

Randomized, double-blind, of standard of care vs additional communication and factorial design of intervention letter vs. control letter and EHR vs mail delivery mechanism in patients who canceled visits and did not reschedule over a 90 day period starting March 9, 2020.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

QUADRUPLE

Enrollment

11,120

Conditions

Communication Research

Interventions

Communication typeOTHER

Control letter vs. intervention letter

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a cancellation or failure to show for a procedure or visit from March 9, 2020 through June 7, 2020 (90 days) and who have not rescheduled as of the date of randomization Exclusion Criteria: * Death

Locations (1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Percent of Participants With Visit or Procedure With Provider

Time frame: 1 month

Secondary Outcomes

Percent of Participants With Scheduled Visit or Procedure With Provider

Time frame: 1 month

Percent of Participants With Completed Telemedicine Visit With Provider

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.